in sera from patients with systemic sclerosis (scleroderma). The authors performed a series of experiments that confirmed that these antibodies recognized and activated native PDGFR on fibroblasts.

A father who takes 250 tablets each week and lives on oxygen due to a rare health phenomenon has exceeded his life expectancy ...

Scleroderma is a rare, progressive autoimmune condition caused by the body producing too much collagen resulting in the ...

Finally, scleroderma can affect patients very differently ... Two thirds of patients with this antibody have diffuse SSc and pulmonary interstitial fibrosis as well as reduced survival.

A case series showed that chimeric antigen receptor T-cell therapy targeting CD19 halted the progression of fibrotic organ ...

Scleroderma, polyarteritis and dermatomyositis ... Negative results were obtained with L.E.-cell preparations and fluorescent-antibody tests on all normal subjects. A few patients with ...